Press Release - Premarket approval for the Neuroform Atlas® Stent System
May 23, 2019
Stryker receives FDA premarket approval for the Neuroform Atlas® Stent System to treat brain aneurysms
More
Press release – Stryker launches next generation flow diverter for treatment of brain aneurysms
April 23, 2019
Stryker announces the availability of the Surpass Evolve Flow Diverter following CE mark approval in March.
More
Innovation, design, and a look to the future of stroke technology
December 3, 2018
An interview with John Daniel, Vice President, Neurovascular R&D
More
Product Bulletin: Surpass Streamline™ Flow Diverter
July 16, 2018
Stryker receives US FDA Pre-market approval for the Surpass Streamline™ Flow Diverter to treat large and giant unruptured aneurysms
More
Trevo Retriever First and Only Device for Treatment up to 24 hrs
February 15, 2018
Stryker’s Trevo® Retriever becomes first and only device indicated for treatment up to 24 hours, aligning with new AHA/ASA guidelines
More
Stryker’s WEAVE Trial demonstrates positive results of endovascular treatment for patients with ICAD
January 26, 2018
Results from the Wingspan® StEnt System Post MArket SurVEillance Study (WEAVE™ Trial) were presented yesterday at the International Stroke Conference, providing compelling evidence that...
More
Stryker’s DAWN Trial results contribute to updated acute ischemic stroke guidelines from the AHA/ASA
January 25, 2018
Yesterday the American Heart Association and American Stroke Association updated the ischemic stroke guidelines. The new recommendation expanded the treatment window from six to 16 hours based...
More
Stryker announces publication of the DAWN™ Trial results in the New England Journal of Medicine
November 13, 2017
The New England Journal of Medicine published the results of the DAWN Trial, the first to provide compelling evidence in treating late window and wake-up stroke patients with mechanical thrombectomy.
More
Stryker receives US FDA HDE approval for the Neuroform Atlas™ Stent System
November 9, 2017
Stryker Corporation announced today that the U.S. Food and Drug Administration has approved the Neuroform Atlas™
MoreCelebrating Stroke Survivors – World Stroke Day 2017
October 20, 2017
Learn more about stroke survivors and stroke treatment.
More
Product Bulletin: DAWN™ Trial Results
May 16, 2017
DAWN™ Trial results demonstrate a 73% reduction in disability in stroke patients treated up to 24 hours.
More
Product Bulletin: DAWN™ Trial
March 7, 2017
Stryker announces an early stop to enrollment in the DAWN™ Trial due to the high probability of trial success.
More
Ann McCafferty discusses the nomination of Trevo® XP ProVue Retriever
January 1, 2017
Ann McCafferty discusses the nomination of Trevo® XP ProVue Retriever for the Prix Galien Discovery of the Decade: Best medical technology product.
More
NEW Indication for Trevo Retrievers
December 30, 2016
The latest Information on the new Indication for Trevo Retrievers
More
Study Published In The New England Journal Of Medicine Finds….
December 17, 2014
Prix Galien-winning Stryker Trevo among those stent retrievers used in the trial
More
Stryker Receives Prestigious 2014 Prix Galien Award For Best Medical Technology
November 12, 2014
Stryker Corporation's Trevo® ProVue Retriever has received the Prix Galien USA 2014 Award for Best Medical Technology.
More